Hites M, Massonnaud CR, Jamard S, Goehringer F, et al. Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): a phase 3, randomized, double-blind, placebo-controlled trial. J Infect 2024 Feb 15:106120. doi: 10.1016/j.jinf.2024.106120.
PMID: 38367705